Explore Atrial Fibrillation Clinical Trials for Potential Novel Treatment Options!
Atrial fibrillation (AFib) is a type of irregular heartbeat that affects the atria, the upper chambers of the heart. According to statistics, AFib causes about 1 in 7 strokes.
The majority of strokes associated with AFib are ischemic strokes, which occurs when a blood clot forms within an artery that supplies blood to the brain. To reduce the risk of stroke in AFib, anticoagulation therapy is often prescribed.
Revival Research Institute is conducting AFib trial exploring potential new treatment options that may reduce the risk of blood clot formation.
You may qualify for Atrial Fibrillation Clinical Trials if you:
- Are at least 18 years or older
- Have been diagnosed with Atrial Fibrillation
*Participating in the AFib trial is at no cost to you or your private medical insurance. You will be reimbursed for your time and travel. In addition, all participants receive study-related care, free of cost from an experienced research team.
**If you are interested in participating in the Atrial Fibrillation Clinical Trials or would like more information, please fill out the form so we can determine if you qualify for the study and contact you. Note that this is an entirely voluntary decision.